Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
FDG-PET for management of cervical and ovarian cancer
Laura J. Havrilesky
,
Shalini L. Kulasingam
, David B. Matchar
, Evan R. Myers
Epidemiology & Community Health
Research output
:
Contribution to journal
›
Article
›
peer-review
257
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'FDG-PET for management of cervical and ovarian cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ovarian Cancer
100%
Cervical Cancer
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Conventional Imaging
100%
Carbohydrate Antigen 125 (CA125)
80%
Clinical Suspicion
40%
Exclusion Criteria
40%
Invasive Cervical Cancer
40%
Imaging Modalities
20%
Patient Assessment
20%
Human Subjects
20%
Imaging Studies
20%
Clinical Follow-up
20%
Diagnostic Performance
20%
Confidence Interval
20%
Patient numbers
20%
MEDLINE
20%
Nodal Metastasis
20%
Lymph Node Metastasis
20%
Fluorodeoxyglucose
20%
Microscopic Residual
20%
Pelvic Node Metastasis
20%
Histopathology
20%
Positron Emission Tomography/computed Tomography (PET/CT)
20%
Text Reviews
20%
Medicine and Dentistry
Ovarian Cancer
100%
Polyethylene Terephthalate
100%
Sensitivity and Specificity
58%
Cervical Cancer
41%
Conventional Imaging
41%
CA-125
33%
Recurrent Disease
16%
Magnetic Resonance Imaging
8%
Human Subject
8%
Pelvis
8%
Positron Emission Tomography
8%
Histopathology
8%
Diagnostic Performance
8%
Fluorodeoxyglucose
8%
Nodal Metastasis
8%